Newsroom

LONDON--(BUSINESS WIRE)--  Commonwealth Bank of Australia Issue of AUD 13,000,000.00 Floating Rate Notes due 24 February 2032 Series no 6455 Tranche 1 MTN ISSUE NAME. Our Ref. MO4624 ISIN Code. XS2448367800 TOTAL INTEREST AMT. CURRENCY CODE. AUD DAY BASIS. ACTUAL/365 FIXED (A005) NUM OF DAYS. 90 INTEREST RATE. 5.3459 PCT VALUE DATE. 24/08/2026 INTEREST PERIOD. 26/05/2026 TO 24/08/2026 AUD 171,361.73 POOL FACTOR. N/A...

LONDON--(BUSINESS WIRE)--  Pershing Square Holdings, Ltd. Announces Transactions in Own Shares - 26 May 2026 Pershing Square Holdings, Ltd. (LN:PSH) (LN:PSHD) (“PSH”) today announced that it has purchased, through PSH’s agent, Jefferies International Limited (“Jefferies”), the following number of PSH’s Public Shares of no par value (ISIN Code: GG00BPFJTF46) (the "Shares"): Total Buyback   Ticker/s: PSH (LSE); PSHD (LSE) Date of Purchase: 26 May 2026 Number of Public Shares Purchased: 21,830 Sha...

LONDON--(BUSINESS WIRE)--  ASB BANK LIMITED Issue of USD 18,000,000.00 Senior Notes due March 2028 Series 6513 Tranche 1 MTN ISSUE NAME. Our Ref. MP4215 ISIN Code. XS2592796747 TOTAL INTEREST AMT. CURRENCY CODE. USD DAY BASIS. Actual/360 (A004) NUM OF DAYS. 92 INTEREST RATE. 4.74533 PCT VALUE DATE. 02/06/2026 INTEREST PERIOD. 02/03/2026 TO 02/06/2026 USD 218,285.18 POOL FACTOR. N/A...

FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today shared new results from a post hoc analysis showing that Livdelzi® (seladelpar) was associated with high and sustained rates of normalization of a key liver marker (ALP) in people living with primary biliary cholangitis (PBC). In an ongoing Phase 3 study, participants with elevated ALP levels (between 1.0 and 1.67×ULN) experienced reductions in ALP after treatment. These data highlight the potential role of Livdelz...

LONDON--(BUSINESS WIRE)--  Australia and New Zealand Banking Group Issue of USD 65,000,000.00 Floating Rate Notes due 2 March 2028 Series 2090 Tranche 1 MTN ISSUE NAME. Our Ref. MP4290 ISIN Code. XS2593135036 INTEREST AMT PER DENOM. CURRENCY CODE. USD DAY BASIS. Actual/360 (A004) NUM OF DAYS. 92 INTEREST RATE. 4.44533 PCT VALUE DATE. 02/06/2026 INTEREST PERIOD. 02/03/2026 TO 02/06/2026 USD 200,000.00 IS USD 2,272.06 POOL FACTOR. N/A...

PARIS--(BUSINESS WIRE)--Regulatory News: In accordance with the authorizations given by the shareholders’ general meeting on May 23, 2025, to trade on its shares and pursuant to applicable law on share repurchase, TotalEnergies SE (Paris:TTE) (LSE:TTE) (NYSE:TTE) (LEI: 529900S21EQ1BO4ESM68) declares the following purchases of its own shares (FR0000120271) from May 18 to May 22, 2026: Transaction Date Total daily volume (number of shares) Daily weighted average purchase price of shares (EUR/shar...

LONDON--(BUSINESS WIRE)--Tide, the UK’s leading business management platform, today announces it has crossed 2 million members globally, with India in particular seeing strong growth. More than 1.1 million small businesses joined Tide in India since the company launched there in December 2022. This makes India Tide’s fastest-growing market by member acquisition. The UK is Tide’s home market, with 900,000 SMEs, 15% market share, and the majority of the company’s revenue. Tide’s steadily expandin...

PARIS--(BUSINESS WIRE)--  In accordance with the authorizations given by the shareholders’ general meeting on May 23, 2025, to trade on its shares and pursuant to applicable law on share repurchase, TotalEnergies SE (Paris:TTE) (LSE:TTE) (NYSE:TTE) (LEI: 529900S21EQ1BO4ESM68) declares the following purchases of its own shares (FR0000120271) from May 18 to May 22, 2026: Transaction Date Total daily volume (number of shares) Daily weighted average purchase price of shares (EUR/share) Amount of tr...

BOLOGNA, Italy--(BUSINESS WIRE)--Alfasigma S.p.A, a global pharmaceutical company with a focus on innovation in rare and specialty care where there is significant unmet patient need, presented positive results from the OLINGUITO Phase 3 clinical trial (NCT05785611i EudraCT 2022-501354-10-01ii) at EULAR 2026. In OLINGUITO filgotinib, an oral, once-daily JAK1 preferential inhibitor under investigation for the treatment of adult patients with active axial spondyloarthritis (axSpA), demonstrated su...

PARIS--(BUSINESS WIRE)--Regulatory News: Dans le cadre des autorisations consenties par l’Assemblée générale du 23 mai 2025 pour opérer sur ses actions et conformément à la réglementation relative aux rachats d'actions, TotalEnergies SE (Paris:TTE) (LSE:TTE) (NYSE:TTE) (LEI : 529900S21EQ1BO4ESM68) déclare ci-après les achats d’actions propres (FR0000120271) réalisés du 18 mai au 22 mai 2026 : Jour de la transaction Volume total journalier (en nombre de titres) Prix pondéré moyen journalier d'ac...